Eton Pharmaceuticals

Home
United States
Deer Park, IL
Eton Pharmaceuticals

Eton Pharmaceuticals is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.

04/29/2026

We’re looking forward to being on the ground at three upcoming meetings and connecting with the clinicians and partners who care for patients living with rare diseases.

Please visit us at:
📍Pediatric Endocrine Society (PES) | April 30-May 2 | San Francisco, CA | Booth # 113
📍 Pediatric Endocrine Nursing Society (PENS) | April 29-May 1 | Columbus, OH | Booth # 110
📍 Digestive Disease Week (DDW) | May 2-5 | Chicago, IL | Booth # 2126

Each of these meetings brings together experts across specialties who play a critical role in diagnosis, treatment, and long-term care.

If you’re attending, we’d welcome the opportunity to connect.

04/27/2026

We’re pleased to share that Eton Pharmaceuticals has initiated a clinical study evaluating ET-700, an investigational extended-release formulation of zinc acetate.

🔗 Read the PR here: https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-announces-initiation-clinical-study-product.

The study is designed as a randomized, double-blind, placebo-controlled trial and will use advanced imaging to better understand copper absorption in individuals living with Wilson disease.

This marks another meaningful step as we continue building our pipeline and our work in rare diseases that require lifelong care.

We’re grateful to the investigators, study participants, and broader community who make this work possible.

04/22/2026

We were thrilled to attend the CARES Foundation's 18th Annual Everyone CARES Gala at Sony Pictures Studios in Culver City, CA this past weekend.

The stories shared by parents, patients, and healthcare providers deeply involved in the care of those living with Congenital Adrenal Hyperplasia (CAH) were incredibly moving. There was a strong sense of gratitude, joy, and connection throughout the evening that stayed with us well beyond the event.

We thank the CARES Foundation for their incredible efforts to improve the lives of patients with CAH and for the support they have given to families, practitioners, and all those involved in the treatment of this disease.

04/20/2026

April is (UCD) Awareness Month!

Most people have never heard of urea cycle disorders, but for many families, it’s part of everyday life. UCDs are rare genetic conditions that affect the body’s ability to remove ammonia from the bloodstream.

This month, we’re joining the community in raising awareness and advocating for those living with UCD.

📣 Help us spread the word.
🩵 Learn. Share. Support. National Urea Cycle Disorders Foundation

04/19/2026

April 19 is , a global awareness effort led by organizations dedicated to liver health and liver disease.

Liver disease can be silent, which is why regular checkups and early attention matter. Identifying issues early can help protect long-term liver health and prevent more serious complications.

This , we join in raising awareness, promoting prevention, and encouraging healthy habits that support liver health worldwide.

Explore resources and join the World Liver Day global effort at www.worldliverday.org.

04/16/2026

Eton Pharmaceuticals was pleased to attend the Wilson Disease Association Spring Support Symposium this past weekend in Ann Arbor, Michigan, alongside our specialty pharmacy partner, AnovoRx.

It was a valuable opportunity to spend time with patients, caregivers, and healthcare professionals and to be part of thoughtful, real conversations around living with this rare disease.

Thank you to everyone who connected with us. We remain committed to working alongside the community to support patients and providers.

04/07/2026

Today, we join the National Adrenal Diseases Foundation in shining a light on adrenal diseases and the people affected by them every day.

We recognize the patients, caregivers, and clinicians whose resilience, advocacy, and work continue to drive progress, expand awareness, and improve lives around the world.

04/01/2026

April is Adrenal Disease Awareness Month.

Adrenal Disease impacts patients and families in ways that are often not visible, making awareness and education especially important.

Join Eton Pharmaceuticals this month in raising awareness, sharing knowledge, and supporting those affected by Adrenal Disease.

03/31/2026

At Eton Pharmaceuticals, everything we do starts with a simple focus: patients.

From expanding access through our Eton Cares Program® to advancing treatments in rare and ultra-rare conditions, our team is committed to making a meaningful difference where it matters most.

Learn more about our mission at www.etonpharma.com.

03/10/2026

Our newest product, Desmoda™ (desmopressin acetate), was featured on the NASDAQ MarketSite board in Times Square.

Seeing Desmoda highlighted in such an iconic place is a meaningful milestone and a reminder of the work that goes into bringing new treatments to patients.

Behind every approval is a tremendous amount of work, collaboration, and belief in the patients we aim to serve. Moments like this are an opportunity to pause and appreciate the progress.

Thank you to everyone who contributed to making this achievement possible.

To learn more about Desmoda please visit: https://desmoda.com

Please see full package insert:https://www.etonpharma.com/wp-content/uploads/2026/02/Combined-Promo-Label-1.pdf

03/06/2026

Last week, we celebrated on Capitol Hill, hosted by the Rare Disease Legislative Advocates, a program of the EveryLife Foundation for Rare Diseases and at Boston Children’s Hospital.

We also had the incredible opportunity to engage with the liver and rare disease communities at the Liver Connect Conference , hosted by the Chronic Liver Disease Foundation.

These events highlight that advancing care for rare diseases relies on collaboration. Patients, families, clinicians, researchers, and advocates each bring unique perspectives, and true progress happens when we unite our efforts.

A heartfelt thank you to the organizers and everyone who made these events possible!

03/02/2026

We are proud to announce that Eton Pharmaceuticals has expanded its rare disease portfolio through the acquisition of U.S. commercialization rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution.

Please read the full press release here: https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-expands-rare-disease-portfolio-through

This milestone represents continued progress in advancing our mission to support patients, families, and healthcare providers in rare disease communities.

Address

21925 W Field Pkwy #235
Deer Park, IL
60010

Website

https://www.etonpharma.com/

Alerts

Be the first to know and let us send you an email when Eton Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Eton Pharmaceuticals:

Shortcuts

Want your practice to be the top-listed Clinic in Deer Park?